InveniAI Announces Launch of AlphaMeld Corporation and Major Milestone Updates to Reflect Cutting-Edge Innovation in AI-Driven Drug Discovery
January 13, 2025 10:00 ET
|
InveniAI LLC
GUILFORD, Conn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- InveniAI LLC, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize...
Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics Report Positive Topline Data from 8 mg Dose of Phase 2 Obesity Trial of GLP-1/GIP Receptor Dual Agonist HRS9531
January 13, 2025 08:00 ET
|
Kailera Therapeutics, Inc.
Kailera and Hengrui Pharma announced positive topline data from the 8 mg dose of Hengrui’s Phase 2 clinical trial of HRS9531, a GLP-1/GIP dual agonist.
BIOA CLASS ACTION ALERT: BioAge Labs Investors that Lost Money are Notified of a Class Action Lawsuit – Contact BFA Law by March 10 Legal Deadline (NASDAQ:BIOA)
January 11, 2025 08:17 ET
|
Bleichmar Fonti & Auld
BioAge Labs, Inc. investors that lost money are encouraged to contact BFA Law before March 10, 2025 class action deadline.
BIOA BREAKING NEWS: What does the BioAge Labs Class Action Mean for You? Contact BFA Law by March 10 Court Deadline (NASDAQ:BIOA)
January 09, 2025 07:11 ET
|
Bleichmar Fonti & Auld
BioAge Labs, Inc. investors that lost money are encouraged to contact BFA Law before March 10, 2025 class action deadline.
Americans Weigh In: International Food Information Council Releases New Research Examining Perceptions Around Obesity & Weight Loss Medications
January 08, 2025 11:23 ET
|
International Food Information Council Foundation
Washington, DC, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The International Food Information Council (IFIC) has published a new survey examining Americans’ attitudes and perceptions toward obesity...
Kailera Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
January 08, 2025 08:05 ET
|
Kailera Therapeutics, Inc.
Kailera Therapeutics today announced the appointment of Laurie Stelzer as Chief Financial Officer.
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity
January 07, 2025 11:00 ET
|
Zealand Pharma
Press Release – No. 2 / 2025 Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity Copenhagen, Denmark, January 7, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL)...
Kailera Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025 08:15 ET
|
Kailera Therapeutics, Inc.
Ron Renaud, Kailera's President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025.
Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity
December 23, 2024 08:30 ET
|
Wave Life Sciences USA, Inc.
WVE-007 is a novel approach for treating obesity and is designed to silence INHBE to achieve healthy, sustainable weight loss through fat burning, muscle maintenance and the potential for once or...
CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes
December 23, 2024 08:01 ET
|
Corxel Pharmaceuticals
CORXEL expands its cardiometabolic pipeline into obesity and diabetes.